Dokter Galle Veerle, Hematologie
0734.556.947 · rovalta.com · 28/09/2026
ACTIVE
Dokter Galle Veerle, Hematologie
Financial year 2025 · Closed on 30/06/2025
Net result176,3 k €+11,2 %over 1 year
Gross margin277,5 k €+7,5 %over 1 year
Equity707,7 k €+33,2 %over 1 year
Overview
Identity
Source · BCE/KBODokter Galle Veerle, Hematologie is a Private limited company incorporated in 2019. Its main activity is: Specialist medical practice activities. Its registered office is in Destelbergen.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0734.556.947
- Incorporation
- 17/09/2019
- Legal form
- Private limited company
- Registered office
- Loveldstraat(HEU) 92
9070 Destelbergen · FlandreSee on map - Contributed capital
- 5 000,00 €
- Latest accounts
- 30/06/2025
Activities (NACE)
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA
Financials
Source · NBB, 7 filingsTrend over 6 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 277,5 k € | +7.5% | 258,3 k € | -4.4% | 270,3 k € | +19.4% | 226,3 k € | +57.7% | 143,5 k € |
| EBITDA | 274,7 k € | +7.1% | 256,4 k € | -4.7% | 269 k € | +19.4% | 225,3 k € | +57.8% | 142,8 k € |
| Operating result | 245,1 k € | +7.4% | 228,2 k € | -7.9% | 247,9 k € | +18.9% | 208,5 k € | +54.2% | 135,2 k € |
| Net result | 176,3 k € | +11.2% | 158,6 k € | -12.1% | 180,4 k € | +25.3% | 143,9 k € | +49.9% | 96 k € |
| Balance sheet | |||||||||
| Equity | 707,7 k € | +33.2% | 531,4 k € | +42.6% | 372,8 k € | +17.5% | 317,4 k € | +83.0% | 173,4 k € |
| Total assets | 1 M € | +21.8% | 821,2 k € | +13.2% | 725,5 k € | -2.1% | 741,1 k € | -2.5% | 760,2 k € |
| Cash | 186 k € | -14.4% | 217,4 k € | +79.1% | 121,4 k € | -64.6% | 342,6 k € | -7.7% | 371,3 k € |
| Debts | 292,6 k € | +1.0% | 289,7 k € | -17.9% | 352,8 k € | -16.7% | 423,7 k € | -27.8% | 586,8 k € |
Valuation
Indicative valuation
As an indication, this company is worth
between 1 M€ and 2,5 M€
See the valuationBoard of directors
Source · NBB, accounts to 30/06/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
VEERLE GALLE | Director |
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/07/2024 | 01/07/2023 | 01/07/2022 | 01/07/2021 | 01/07/2020 | 17/09/2019 |
| Closing of the financial year | 30/06/2025 | 30/06/2024 | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 10 months |
| Filing date | 28/02/2026 | 29/12/2024 | 01/02/2024 | 31/01/2023 | 30/03/2022 | 30/12/2020 |
| General meeting | 26/12/2025 | 27/12/2024 | 29/12/2023 | 30/12/2022 | 31/12/2021 | 25/12/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 7 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/06/2025 | 26/12/2025 | 28/02/2026 | Dutch | |
| Micro model | 30/06/2024 | 27/12/2024 | 29/12/2024 | Dutch | |
| Micro modelCorrection | 30/06/2023 | 29/12/2023 | 01/02/2024 | Dutch | |
| Micro model | 30/06/2023 | 29/12/2023 | 08/01/2024 | Dutch | |
| Micro model | 30/06/2022 | 30/12/2022 | 31/01/2023 | Dutch | |
| Micro model | 30/06/2021 | 31/12/2021 | 30/03/2022 | Dutch | |
| Micro model | 30/06/2020 | 25/12/2020 | 30/12/2020 | Dutch |
Valuation
Indicative valuation
Order of magnitude
As an indication, this company is worth
between 1 M€ and 2,5 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/06/20251 active
Active mandates
| Director | Mandates in this company | Period |
|---|---|---|
VEERLE GALLE | Director |
Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Other19/09/2019RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
Source · CBE, NBB annual accountsYear
Identity
Incorporation
Name
Registered office
Annual accounts
Filings6 filings
20192020202120222023202420252026
DR GALLE VEERLE
Loveldstraat(HEU) 92, 9070 Destelbergen
CurrentPlanned, not yet servedEndedAccounts filedToday
Registered offices
Source · NBB annual accounts, CBE| Registered address | Period | Source |
|---|---|---|
| Loveldstraat(HEU) 92, 9070 DestelbergenCurrent | accounts 2022 → 2025 | Accounts 2025 · 2026-00045972 |
Company names
Source · NBB annual accounts, CBE| Name | Period | Source |
|---|---|---|
| Dokter Galle Veerle, HematologieCurrent | CBE | |
| DR GALLE VEERLE | accounts 2022 → 2025 | Accounts 2025 · 2026-00045972 |
Events
- 2025Annual accounts 2025176,3 k €↑
- 2024Annual accounts 2024158,6 k €↓
- 2023Annual accounts 2023180,4 k €↑
- 2022Annual accounts 2022143,9 k €↑
- 2021Annual accounts 202196 k €↑
- 2020Annual accounts 202072,4 k €
- 17/09/2019IncorporationPrivate limited company